Chairman & CEO of United Therapeutics Corp (30-Year Financial, Insider Trades) Martine A Rothblatt (insider trades) sold 20,000 shares of UTHR on 06/19/2020 at an average price of $116.35 a share. The total sale was $2.3 million.
United Therapeutics Corp is engaged in the healthcare sector. Its core offering includes pharmaceutical products to address unmet medical needs of patients. United Therapeutics Corp has a market cap of $5.21 billion; its shares were traded at around $118.36 with a P/E ratio of 9.88 and P/S ratio of 3.62. GuruFocus has detected 2 severe warning signs with United Therapeutics Corp. .
CEO Recent Trades:
- Chairman & CEO Martine A Rothblatt sold 20,000 shares of UTHR stock on 06/19/2020 at the average price of $116.35. The price of the stock has increased by 1.73% since.
- Chairman & CEO Martine A Rothblatt sold 30,000 shares of UTHR stock on 06/17/2020 at the average price of $115.33. The price of the stock has increased by 2.63% since.
- Chairman & CEO Martine A Rothblatt sold 20,000 shares of UTHR stock on 06/12/2020 at the average price of $116.86. The price of the stock has increased by 1.28% since.
- Chairman & CEO Martine A Rothblatt sold 30,000 shares of UTHR stock on 06/10/2020 at the average price of $125.08. The price of the stock has decreased by 5.37% since.
- Chairman & CEO Martine A Rothblatt sold 20,000 shares of UTHR stock on 06/05/2020 at the average price of $123.57. The price of the stock has decreased by 4.22% since.
Directors and Officers Recent Trades:
- Director Tommy G Thompson sold 4,210 shares of UTHR stock on 06/09/2020 at the average price of $126.79. The price of the stock has decreased by 6.65% since.
- Director Judy D. Olian sold 4,510 shares of UTHR stock on 06/08/2020 at the average price of $124.96. The price of the stock has decreased by 5.28% since.
For the complete insider trading history of UTHR, click here
.
